In the European Union, decisions on pricing and reimbursement of medicinal products are made at a national level following negotiations between governments and Marketing Authorisation Holders (MAH). In France, after obtaini (...)
Read moreMedicine prices: is France still an attractive market?
Posted 2023-03-21